
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 4-[2-[5-[1-[6-[2-[2-[2-[[N-[(4S)-4-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]-5-[(2S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-carboxy-3-methyl-butyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-5-oxo-pentyl]carbamimidoyl]carbamoylamino]ethoxy]ethoxy]ethylamino]-6-oxo-hexyl]-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-1-yl]butane-1-sulfonate 2,2,2-trifluoroacetic acid's neighborhood in the knowledge graph.

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 4-[2-[5-[1-[6-[2-[2-[2-[[N-[(4S)-4-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]-5-[(2S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-carboxy-3-methyl-butyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-5-oxo-pentyl]carbamimidoyl]carbamoylamino]ethoxy]ethoxy]ethylamino]-6-oxo-hexyl]-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-1-yl]butane-1-sulfonate 2,2,2-trifluoroacetic acid.

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 4-[2-[5-[1-[6-[2-[2-[2-[[N-[(4S)-4-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]-5-[(2S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-carboxy-3-methyl-butyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-5-oxo-pentyl]carbamimidoyl]carbamoylamino]ethoxy]ethoxy]ethylamino]-6-oxo-hexyl]-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-1-yl]butane-1-sulfonate 2,2,2-trifluoroacetic acid.
4-[2-[5-[1-[6-[2-[2-[2-[[N-[(4S)-4-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]-5-[(2S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-carboxy-3-methyl-butyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-5-oxo-pentyl]carbamimidoyl]carbamoylamino]ethoxy]ethoxy]ethylamino]-6-oxo-hexyl]-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-1-yl]butane-1-sulfonate 2,2,2-trifluoroacetic acid bioactivity Neurotensin receptor type 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
4-[2-[5-[1-[6-[2-[2-[2-[[N-[(4S)-4-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]-5-[(2S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-carboxy-3-methyl-butyl]carbamoyl]-2-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-5-oxo-pentyl]carbamimidoyl]carbamoylamino]ethoxy]ethoxy]ethylamino]-6-oxo-hexyl]-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-1-yl]butane-1-sulfonate 2,2,2-trifluoroacetic acid bioactivity Neurotensin receptor type 1
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG